Churchill Management’s Bristol-Myers Squibb BMY Stock Holding History

Churchill Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-58,153	Closed	-$4.18M	–	131
2022 Q4	$4.18M	Sell	58,153 -1,695	-3%	-$128K	0.1%	87
2022 Q3	$4.25M	Buy	59,848 +590	+1%	+$42.8K	0.11%	91
2022 Q2	$4.56M	Buy	+59,258	New	+$4.51M	0.11%	93
2020 Q4	–	Sell	-111,238	Closed	-$6.71M	–	132
2020 Q3	$6.71M	Buy	111,238 +5,447	+5%	+$328K	0.16%	81
2020 Q2	$6.22M	Buy	105,791 +10,180	+11%	+$609K	0.19%	72
2020 Q1	$5.33M	Buy	95,611 +1,348	+1%	+$82.4K	0.27%	64
2019 Q4	$6.05M	Buy	+94,263	New	+$5.4M	0.12%	85
2014 Q2	–	Sell	-55,941	Closed	-$2.91M	–	185
2014 Q1	$2.91M	Sell	55,941 -2,407	-4%	-$128K	0.11%	86
2013 Q4	$3.1M	Sell	58,348 -3,326	-5%	-$169K	0.12%	63
2013 Q3	$2.85M	Sell	61,674 -3,595	-6%	-$158K	0.15%	42
2013 Q2	$2.92M	Buy	+65,269	New	+$2.83M	0.14%	47

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Churchill Management's BMY Position: Q1 2023 in Review

Churchill Management sold out of Bristol-Myers Squibb (BMY) in Q1 2023, closing a stake of 58,153 shares — an estimated $4.18M sold.

Churchill Management first reported a position in BMY in Q2 2013 and held it in 11 quarters. The position peaked at $6.71M in Q3 2020. 2,540 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

Churchill Management reported no remaining Bristol-Myers Squibb position as of Q1 2023 after selling out during the quarter.
Churchill Management sold 58,153 Bristol-Myers Squibb shares in Q1 2023, an estimated $4.18M.
Churchill Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 11 quarters.
Churchill Management's Bristol-Myers Squibb position peaked at $6.71M in Q3 2020.
2,540 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on Churchill Management's 13F filing for Q1 2023, filed 13 Apr 2023.